The pharmaceutical industry is a vital part of the search for new treatments for dementia, they have the expertise and resources to invest in clinical trials.
Page last reviewed: 18/06/2018
Source: Dementia Discovery Fund (2018)
Source: What is the relationship between public and private investment in science, research and innovation? (2015) by Economic Insight commissioned by the Department of Business, Innovation and Skills
Source: Business enterprise research and development, UK: 2016; Office of National Statistics
Source: Strength and Opportunity 2017 The landscape of the medical technology, medical biotechnology, pharmaceutical and industrial biotechnology sectors in the UK; Office of Life Sciences and UK Trade and Investment
Source: Choi, DW et al (2014) Medicines for the Mind: Policy-Based “Pull” Incentives for Creating Breakthrough CNS Drugs; Neuron 84, 3, 554-563
The pharmaceutical sector in the UK performs by far the most research and development (R&D) of any business sector and has done so for the last decade, accounting for more than 18% of the total in 2016.
Source: Business enterprise research and development, UK: 2016; Office of National Statistics